Press Releases

Featured Press Releases

BIO Statement Regarding Nomination of Robert F…

BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…

Learn more

BIO Released the Following Statement After…

“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…

Learn more

BIO Statement on Lawsuit Over 340B Rebates

BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…

Learn more

New BIO Report Dispels the Myth of the Blend Wall and High RIN Prices

October 4, 2016

Data recently released by EPA on compliance with the Renewable Fuel Standard between 2010 and 2013 (the latest year for which compliance is complete) challenges the widely accepted assumption that the blend wall – the point at which ethanol blending…

BIO Statement on Biosimilar User Fee Act Goals Letter

September 26, 2016

Washington, D.C. (September 16, 2016) – Biotechnology Innovation Organization (BIO) Senior Vice President for Science Policy Kay Holcombe released the following statement today regarding the Biosimilar User Fee Act (BsUFA) II goals letter:

BIO Applauds Senate Passage of Advancing Hope Act

September 23, 2016

Washington, D.C. (September 23, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement today regarding Senate passage of the Advancing Hope Act of 2016:

BIO Statement Regarding the UN High Level Panel on Access to Medicines Report

September 14, 2016

Sadly the United Nations High Level Panel ignored the real issues that impact or delay delivery of innovative treatments and cures throughout the developing world, while focusing on policy recommendations in the one area –…

BIO Investor Forum 2016 Programming Announced

September 7, 2016

BIO announced programming for the 15th annual BIO Investor Forum. Held on October 18-19 at the Westin St. Francis Hotel in San Francisco, the BIO Investor Forum explores global investment trends and opportunities in life sciences. Early and mid…

BIO Releases New Report on Renewable Chemical Biorefinery Commercialization

September 7, 2016

BIO released the new report “Advancing the Biobased Economy: Renewable Chemical Biorefinery Commercialization, Progress, and Market Opportunities, 2016 and Beyond,” documenting substantial, ongoing growth in the renewable chemical industry and…

BIO Launches “Innovation Saves” Ad to Highlight Value of Biopharmaceutical Innovation

September 6, 2016

BIO launched a new television ad focused on biopharmaceutical innovation and its unique ability to help both save lives and save money. The new ad, along with its “Innovation Saves” website, is a new chapter in BIO’s Value Campaign, which…

Life Sciences Community Joins Rep. Charlie Dent to Discuss State of the Industry and Positive Impact on Pennsylvania

August 18, 2016

Pennsylvania’s concentration of bioscience employment is nine percent greater than national average

Biotechnology Innovation Organization and Biominas Brasil to Co-Host BIO Latin America Conference

August 3, 2016

Meeting will bring together biotechnology executives, academics and investors from around the globe

New PBS Film and 2016 BIO Animal Biotech Summit Highlight Biotech Solutions to Combating Emerging Infectious Diseases

August 1, 2016

Programming at this year’s Animal Biotech Summit, Advancing One Health through Biotechnology, will look at how biotechnology can be used in emerging infectious disease surveillance and rapid diagnosis, while highlighting the flexibility…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.